FADIC
JULY 14, 2024
OTC drugs come in various forms, including tablets, capsules, creams, and liquids, and are generally labeled with clear instructions on proper usage and dosage. The FDA’s website provides a wealth of information on OTC drugs, including product labels, warnings, and recalls.
Pharmaceutical Technology
MAY 3, 2023
With this recent news, San Francisco-based Tenaya is initiating a multi-centre, open-label Phase Ib clinical trial for the drug. According to the Mayo Clinic, HCM refers to “a disease in which the heart muscle becomes thickened (hypertrophied)”. HCM is the most common inherited cardiac disorder.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Putting Patients First Blog
DECEMBER 5, 2024
Real-world case studies demonstrating how PPI has influenced decisions, such as targeted approvals or label modifications, would clarify its practical utility. 20 Specialized patient labeling should describe patient preferences for specific benefits and risks, tailored to the population most likely to use the device. 1 (2024): 159171.
The Thyroid Pharmacist
OCTOBER 25, 2022
Fibrocystic breasts used to be labeled as a disease, but given how common they are, they’re now simply referred to as “fibrocystic breasts.” (7) Mayo Clinic. The prevalence of benign breast diseases in patients with nodular goiter and Hashimoto’s thyroiditis. J Endocrinol Invest. 2015;38(9):971-975. Fibrocystic breasts.
pharmaphorum
DECEMBER 14, 2022
The company now intends to discuss the data with regulators, with a view to expanding Blincyto’s label. “Patients who are MRD negative have a better prognosis than patients who are MRD positive, generally, but they still relapse,” commented Mark Litzow of the Mayo Clinic, who presented the data at ASH.
Pharmacy Times
JUNE 16, 2025
The findings emphasize nemolizumab’s swift response in treating atopic dermatitis symptoms, along with its long-term effectiveness in prurigo nodularis, as demonstrated in the OLYMPIA open-label extension trial (NCT04204616). Mayo Clinic. News release. June 6, 2025. Accessed June 16, 2025. Atopic Dermatitis. News release.
Pharmacy Times
JUNE 23, 2025
“This act…allowed a pathway for manufacturers to create a ‘copy’ of a licensed patent product to make it cheaper and more discounted,” Soefje, director of pharmacy cancer care services and associate professor of pharmacy at Mayo Clinic in Rochester, Minnesota, said at the HOPA conference.
Expert insights. Personalized for you.
105 
Let's personalize your content